Cellectar Biosciences, Inc. (CLRB)
2.76
-0.06
(-2.13%)
USD |
NASDAQ |
Apr 10, 16:00
2.80
+0.04
(+1.45%)
After-Hours: 20:00
Cellectar Biosciences EPS Diluted (Quarterly) : -1.249 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| EyePoint Plc | -0.8143 |
| Ocugen, Inc. | -0.0567 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1341 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -5.295M |
| Total Expenses (Quarterly) | 5.295M |
| Enterprise Value | 0.8191M |
| Earnings Yield | -224.1% |
| Normalized Earnings Yield | -235.92 |